|
1.
|
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. MedStar authors:
Year: 2022
Citation: - International Journal of Molecular Sciences. 23(4), 2022 Feb 20.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Alobaidi R, Carney B, Clark H, Dougherty R, Haribabu Y, Kuo LW, Rosenthal DS, Simbulan-Rosenthal CM, Sykora P, Vakili S
|
|
2.
|
Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study. MedStar authors:
Year: 2018
Citation: - Toxicology & Applied Pharmacology. 348:123-129, 2018 06 01.
Institution: - MedStar Health Research Instituteason G
Medline publication type:
All authors: - Balakrishnan P, Best LG, Cole SA, Franceschini N, Francesconi KA, Goessler W, Gribble MO, Haack K, Navas-Acien A, North KE, Umans JG, Vaidya D, Voruganti VS
|